Data shows Shingrix provides protection against shingles in adults
The final trial data demonstrate that Shingrix maintains efficacy against shingles for more than a decade in adults over 50
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Shingrix
GSK launches shingles vaccine, Shingrix in India
Shingrix is a non-live, recombinant subunit vaccine to be given intramuscularly in two doses for the prevention of shingles…
Shingrix can provide at least 10 years of protection against shingles in adults aged 50 years and…
GSK plans to bring Shingrix to India in 2023
Moderna to develop mRNA-based shingles vaccine
The success of COVID-19 vaccines based on messenger RNA (mRNA) technology from Moderna and rival Pfizer has prompted efforts to…
US FDA approves Shingrix to prevent shingles in immuno-compromised adults
Shingrix, a non-live, recombinant sub-unit adjuvanted vaccine, given intramuscularly in two doses, was initially approved by FDA…